Your Good Health: Long-term use of high-dose gabapentin worries patient
The evidence of gabapentin and dementia is mixed, with two studies looking at hundreds of thousands of people and coming to ...
STAT6h
Dementia risk, higher than thought, requires a national strategy
The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...
Alzheimer's Research UK7h
Kent Downs 50km Challenge!
A challenge event you can take on at your pace. The Kent Downs 50 Challenge invites you to walk, jog or run a distance of your choice, along a signed route, with free food and drink at regular rest ...
WebMD18h
Has Our Dementia Risk Doubled? Don’t Panic – Here’s What to Do
Recent headlines suggest that up to 42% of people ages 55 and older face an eventual dementia diagnosis. But some experts have a follow-up message: Risk isn't the same as destiny, and there are ways ...
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Medicare’s 2025 Drug Negotiation List Includes Ozempic and Wegovy
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Ozempic among drugs selected for Medicare price negotiations as Biden exits
Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...